Stojanovic A - Search Results

1

TGF-β2 silencing to target biliary-derived liver diseases.

Dropmann A, Dooley S, Dewidar B, Hammad S, Dediulia T, Werle J, Hartwig V, Ghafoory S, Woelfl S, Korhonen H, Janicot M, Wosikowski K, Itzel T, Teufel A, Schuppan D, Stojanovic A, Cerwenka A, Nittka S, Piiper A, Gaiser T, Beraza N, Milkiewicz M, Milkiewicz P, Brain JG, Jones DEJ, Weiss TS, Zanger UM, Ebert M, Meindl-Beinker NM. Dropmann A, et al. Among authors: stojanovic a. Gut. 2020 Sep;69(9):1677-1690. doi: 10.1136/gutjnl-2019-319091. Epub 2020 Jan 28. Gut. 2020. PMID: 31992593 Free PMC article.

2

Natural killer cells and solid tumors.

Stojanovic A, Cerwenka A. Stojanovic A, et al. J Innate Immun. 2011;3(4):355-64. doi: 10.1159/000325465. Epub 2011 Apr 18. J Innate Immun. 2011. PMID: 21502747 Free article. Review.

3

Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.

Schlecker E, Stojanovic A, Eisen C, Quack C, Falk CS, Umansky V, Cerwenka A. Schlecker E, et al. Among authors: stojanovic a. J Immunol. 2012 Dec 15;189(12):5602-11. doi: 10.4049/jimmunol.1201018. Epub 2012 Nov 14. J Immunol. 2012. PMID: 23152559

4

Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.

Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. Ni J, et al. Among authors: stojanovic a. J Exp Med. 2012 Dec 17;209(13):2351-65. doi: 10.1084/jem.20120944. Epub 2012 Dec 3. J Exp Med. 2012. PMID: 23209317 Free PMC article.

5

Shaping of NK cell responses by the tumor microenvironment.

Stojanovic A, Correia MP, Cerwenka A. Stojanovic A, et al. Cancer Microenviron. 2013 Aug;6(2):135-46. doi: 10.1007/s12307-012-0125-8. Epub 2012 Dec 16. Cancer Microenviron. 2013. PMID: 23242671 Free PMC article.

6

Toward the next generation of NK cell-based adoptive cancer immunotherapy.

Ni J, Miller M, Stojanovic A, Cerwenka A. Ni J, et al. Among authors: stojanovic a. Oncoimmunology. 2013 Apr 1;2(4):e23811. doi: 10.4161/onci.23811. Oncoimmunology. 2013. PMID: 23734329 Free PMC article.

7

CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-γ production in response to mature dendritic cells.

Stojanovic A, Fiegler N, Brunner-Weinzierl M, Cerwenka A. Stojanovic A, et al. J Immunol. 2014 May 1;192(9):4184-91. doi: 10.4049/jimmunol.1302091. Epub 2014 Mar 31. J Immunol. 2014. PMID: 24688023

8

Early inflammatory players in cutanous fibrosis.

Raker V, Haub J, Stojanovic A, Cerwenka A, Schuppan D, Steinbrink K. Raker V, et al. Among authors: stojanovic a. J Dermatol Sci. 2017 Sep;87(3):228-235. doi: 10.1016/j.jdermsci.2017.06.009. Epub 2017 Jun 15. J Dermatol Sci. 2017. PMID: 28655471 Review.

9

The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease.

Stojanovic A, Correia MP, Cerwenka A. Stojanovic A, et al. Front Immunol. 2018 Apr 23;9:827. doi: 10.3389/fimmu.2018.00827. eCollection 2018. Front Immunol. 2018. PMID: 29740438 Free PMC article. Review.

10

Distinct human circulating NKp30⁺FcεRIγ⁺CD8⁺ T cell population exhibiting high natural killer-like antitumor potential.

Correia MP, Stojanovic A, Bauer K, Juraeva D, Tykocinski LO, Lorenz HM, Brors B, Cerwenka A. Correia MP, et al. Among authors: stojanovic a. Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E5980-E5989. doi: 10.1073/pnas.1720564115. Epub 2018 Jun 12. Proc Natl Acad Sci U S A. 2018. PMID: 29895693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page